Promoter holding
64.27%
BM
Bpl Medical Technologies - Due diligence report
A 360° intelligence report on Bpl Medical Technologies: trust score, financial health, credit view, compliance, directors, growth and distre…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Bpl Medical Technologies — 360° Intelligence Report
Generated from MCA filings & public records67/100
Trust Score
Moderate
Bpl Medical Technologies is assessed as Moderate with a Trust Score of 67/100. Bpl Medical Technologies is an active private limited indian non-government company incorporated in 2012, operating in the Healthcare sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and moderate financial risk profile.
Report generated on 03 Oct 2026 from the latest processed filings. Bpl Medical Technologies Private Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreModerate
67/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
66/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
70/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
85/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreCaution Indicated
35/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
90/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
65/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Consolidated · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 85/100 Low Risk
- Liabilities ≈ 38% EBITDA - serviceable.
- Working-capital cover adequate.
- Profitable - internal accruals available.
Charges position: 1 open (140.00 cr) · 3 satisfied (45.00 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Hdfc Bank Limited | 2 | 48.0 cr |
| Yes Bank Limited | 2 | 48.0 cr |
Compliance Score: 66/100 Moderate
- Company status is Active as per MCA.
- Balance sheet slightly behind (Mar 2025).
- Litigation present in 2 court forum(s).
- Delayed payments to MSME suppliers disclosed (16 disclosure(s)).
- 15 active GST registration(s).
Legal cases on record (2)
05
Director Intelligence
Stability score: 35/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| ANJU CHANDRASEKHAR | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| AJIT GOPAL NAMBIAR | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| CHANDRA SEKHAR REDDY GARISA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| ABHAY MAHESHWARI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| DILIP JOSE PUTHIYIDATHU | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SUNIL KUMAR KHURANA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SHRAVAN SUBRAMANYAM | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Mr. Ajay Jindal | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| GURUSWAMY KRISHNAMOORTHY | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Bangi Sadappa Vijay Kumar | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Guruswamy Krishnamoorthy | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 11 directors on the board.
- SHRAVAN SUBRAMANYAM has DIN status "Deactivated due to non-filing of DIR-3 KYC".
- 4 director exits in 3 years - high churn.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2023)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2025 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Beep Investments (singapore) Pte Ltd.,
Subsidiaries
-
Group entities
-
Capital events
9 allotment(s) · 0 transfer(s)
Promoters hold a majority stake - exact percentages are part of the full report.
| Group entity | Relationship | % held |
|---|---|---|
| Beep Investments (singapore) Pte Ltd., | Holding Company | 74.00% |
Key managerial personnel: SUNIL KUMAR KHURANA (Whole-time director) · SHRAVAN SUBRAMANYAM (Managing Director) · Mr. Ajay Jindal (CFO) · GURUSWAMY KRISHNAMOORTHY (CEO)
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 90 · Distress 65
Growth signals & trust indicators
Revenue acceleration: +1.42 over 4 year(s).
Profit expanded 2.1x year-on-year.
Net margin improved to 24%.
EPFO headcount growing - hiring signal.
Operating for 13+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
4 director exits within 2 years.
1 open charge(s) registered - assets are encumbered.
MSME payment delays disclosed - latest outstanding 5.84 Lakh.
2 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence66/100
Review suggested
Suitability as a supplier / customer counterparty.
- Check the compliance flags before onboarding.
- 2 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment76/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 1 open charge(s) of 140.00 cr already registered.
- Compliance gaps should be priced into terms.
Investor view77/100
Positive growth indicators
Growth quality and scalability through an investor lens.
- 4 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management churn warrants questions.
09
MCA Filings & Events Timeline
Latest 15 events08 Dec 2025
Director appointed
ABHAY MAHESHWARI (Nominee Director)
30 Sep 2025
Last AGM held
Annual general meeting
23 Jul 2025
Director appointed
Guruswamy Krishnamoorthy (Ceo)
28 May 2025
Director appointed
DILIP JOSE PUTHIYIDATHU (Nominee Director)
19 May 2025
Director ceased
SHYAM POWAR
12 May 2025
Director appointed
CHANDRA SEKHAR REDDY GARISA (Nominee Director)
22 Apr 2025
Director ceased
RAJESH KRISHNASWAMY MOORTI
02 Apr 2025
Director appointed
SHRAVAN SUBRAMANYAM (Managing Director)
Director appointed
GURUSWAMY KRISHNAMOORTHY (CEO)
Director ceased
SHRAVAN SUBRAMANYAM
01 Apr 2025
Director ceased
SUNIL KUMAR KHURANA
31 Mar 2025
Latest balance sheet
Filed with ROC
11 Jun 2024
Director appointed
Bangi Sadappa Vijay Kumar (Company Secretary)
30 Sep 2022
Director ceased
SHASHANK
31 Dec 2021
Director ceased
SRIRAM KUMAR
10
Key Observations
Auto-generated from the data aboveRevenue grew 0.86 over the last 4 financial year(s).
Net profit margin moved from 61% to 38%.
Net worth is positive.
11 active director(s) / partner(s); review board churn before relying on management continuity.
15 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a majority stake as per the FY 2025 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 9 security allotment(s) - amounts available in the full report.
| Company | CIN | Location |
|---|---|---|
| Vijayanagar Sugar | U15425TG2007PTC052903 | Hyderabad, Telangana, India |
| Advance Agrolife Limited | L24121RJ2002PLC017467 | Jaipur, Rajasthan, India |
| The Sleep Company | U24304MH2019PTC333446 | Jogeshwari West, Maharashtra, India |
| Manohar Lal Sarraf & Sons Jewellers | U36911DL2003PTC122428 | New Delhi, Delhi, India |
| Agappe | U24239MH1998PLC115413 | Mumbai, Maharashtra, India |
| Caregroup Sight Solution | U33100MH2020PTC335344 | Mumbai, Maharashtra, India |
| Vinayak Oil & Fats Private Limited | U51909WB1997PTC085696 | Howrah, West Bengal, India |
| Arl Infratech | U26932RJ1996PLC012146 | Jaipur, Rajasthan, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Bpl Medical Technologies before audits and certifications: compliance score 66/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Bpl Medical Technologies: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Favourable lending indicators. Credit risk score 85/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Positive growth indicators. Growth score 90/100, margin trends, ownership structure and peer set for Bpl Medical Technologies - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Review suggested. Trust score 67/100, distress signals and MSME payment-delay disclosures - know whether Bpl Medical Technologies pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (2 case(s) on record), regulatory flags, charge documents trail and director networks for Bpl Medical Technologies - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Bpl Medical Technologies an active company?
Bpl Medical Technologies has MCA status “Active” with a compliance score of 66/100 (Moderate).
Is Bpl Medical Technologies financially healthy?
Bpl Medical Technologies has a Financial Health Score of 70/100 (Moderate) based on its filed financial statements.
Should I do business with Bpl Medical Technologies?
Its overall Trust Score is 67/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Bpl Medical Technologies?
The ultimate holding entity is Beep Investments (singapore) Pte Ltd.,. 11 active director(s) are on record.
Does Bpl Medical Technologies have loans or charges against its assets?
1 open charge(s) are registered against its assets, and 3 earlier charge(s) stand satisfied.
Is Bpl Medical Technologies up to date with its ROC filings?
Balance sheet slightly behind (Mar 2025). Overall compliance score: 66/100 (Moderate).
Is it risky to lend to Bpl Medical Technologies?
Its Credit Risk Score is 85/100 (Low Risk). Banker verdict: Favourable lending indicators.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
